JW Pharmaceutical Corporation (KRX:001060)
South Korea flag South Korea · Delayed Price · Currency is KRW
22,400
+500 (2.28%)
At close: Mar 24, 2025, 3:30 PM KST

JW Pharmaceutical Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Operating Revenue
719,376748,527684,351606,585547,336
Upgrade
Other Revenue
-0-0---
Upgrade
Revenue
719,376748,527684,351606,585547,336
Upgrade
Revenue Growth (YoY)
-3.89%9.38%12.82%10.82%7.04%
Upgrade
Cost of Revenue
395,878412,984396,397372,209369,810
Upgrade
Gross Profit
323,498335,542287,955234,376177,526
Upgrade
Selling, General & Admin
210,610204,728182,652171,220149,035
Upgrade
Research & Development
36,23733,67133,73619,88422,943
Upgrade
Operating Expenses
240,766238,911227,464203,528178,849
Upgrade
Operating Income
82,73396,63160,49030,848-1,323
Upgrade
Interest Expense
-10,033-12,562-9,387-7,337-7,587
Upgrade
Interest & Investment Income
4,9626,3225,8141,981632.79
Upgrade
Earnings From Equity Investments
1,387621.06-955.41-1,149-1,924
Upgrade
Currency Exchange Gain (Loss)
1,087-1,817-2,300-925.96-2,214
Upgrade
Other Non Operating Income (Expenses)
2,253-36,1025,425-1,191-777.66
Upgrade
EBT Excluding Unusual Items
82,39053,09559,08822,227-13,193
Upgrade
Gain (Loss) on Sale of Investments
790.92,830-8,908-646.8-
Upgrade
Gain (Loss) on Sale of Assets
464.91-1,0883.28-1,048-12.24
Upgrade
Asset Writedown
-1,476--4,821--
Upgrade
Other Unusual Items
249.74----
Upgrade
Pretax Income
82,42054,83645,36220,533-13,205
Upgrade
Income Tax Expense
17,37916,40615,50921,9742,070
Upgrade
Earnings From Continuing Operations
65,04038,43029,853-1,441-15,275
Upgrade
Minority Interest in Earnings
--1,4242,039473.634.19
Upgrade
Net Income
65,04037,00631,892-967.85-15,241
Upgrade
Net Income to Common
65,04037,00631,892-967.85-15,241
Upgrade
Net Income Growth
75.75%16.04%---
Upgrade
Shares Outstanding (Basic)
2324232323
Upgrade
Shares Outstanding (Diluted)
2324232323
Upgrade
Shares Change (YoY)
-2.01%2.49%0.07%-0.05%0.04%
Upgrade
EPS (Basic)
2788.471554.671373.14-41.70-656.37
Upgrade
EPS (Diluted)
2788.471554.671373.14-41.70-656.37
Upgrade
EPS Growth
79.36%13.22%---
Upgrade
Free Cash Flow
71,07959,87146,84510,65750,667
Upgrade
Free Cash Flow Per Share
3047.372515.252016.97459.202182.01
Upgrade
Dividend Per Share
450.000----
Upgrade
Gross Margin
44.97%44.83%42.08%38.64%32.44%
Upgrade
Operating Margin
11.50%12.91%8.84%5.08%-0.24%
Upgrade
Profit Margin
9.04%4.94%4.66%-0.16%-2.79%
Upgrade
Free Cash Flow Margin
9.88%8.00%6.84%1.76%9.26%
Upgrade
EBITDA
101,834119,20677,32746,96019,365
Upgrade
EBITDA Margin
14.16%15.93%11.30%7.74%3.54%
Upgrade
D&A For EBITDA
19,10122,57516,83616,11220,688
Upgrade
EBIT
82,73396,63160,49030,848-1,323
Upgrade
EBIT Margin
11.50%12.91%8.84%5.08%-0.24%
Upgrade
Effective Tax Rate
21.09%29.92%34.19%107.02%-
Upgrade
Advertising Expenses
24,25222,69022,67318,41615,067
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.